Industry / Pharmaceutical Preparation Manufacturing
Trending Companies
Latest filings
DEFA14A
MED
Medifast
26 Apr 24
Additional proxy soliciting materials
5:19pm
DEF 14A
MED
Medifast
26 Apr 24
Definitive proxy
5:17pm
ARS
2023 FY
TCRT
Alaunos Therapeutics
26 Apr 24
Annual report to shareholders
4:52pm
DEFA14A
TCRT
Alaunos Therapeutics
26 Apr 24
Additional proxy soliciting materials
4:49pm
DEF 14A
TCRT
Alaunos Therapeutics
26 Apr 24
Definitive proxy
4:45pm
10-K/A
2023 FY
JAZZ
Jazz Pharmaceuticals
26 Apr 24
Annual report (amended)
4:39pm
ARS
2023 FY
AXSM
Axsome Therapeutics
26 Apr 24
Annual report to shareholders
4:33pm
DEF 14A
AXSM
Axsome Therapeutics
26 Apr 24
Definitive proxy
4:32pm
8-K
EBS
Emergent Biosolutions
26 Apr 24
Departure of Directors or Certain Officers
4:30pm
6-K
MOR
Morphosys
26 Apr 24
Current report (foreign)
10:11am
Upcoming Earnings Releases
MOR
Morphosys
$1,379.7 mm
29 Apr 24
SVA
Sinovac Biotech
$643.8 mm
29 Apr 24
MED
Medifast
$580.4 mm
29 Apr 24
JAZZ
Jazz Pharmaceuticals
$7,336.7 mm
1 May 24
GSK
GSK
$81,560.8 mm
1 May 24
UTHR
United Therapeutics
$10,238.5 mm
1 May 24
SUPN
Supernus Pharmaceuticals
$1,510.6 mm
8 May 24
TCRT
Alaunos Therapeutics
$28.3 mm
8 May 24
EBS
Emergent Biosolutions
$94.9 mm
9 May 24
IGXT
IntelGenx Technologies
9 May 24
Stock splits Upcoming and recent stock splits
News
COVID-19 Patent Dispute Sorted: Acuitas Therapeutics and CureVac Reach Settlement In Patent Battle
BNTX
CVAC
GSK
26 Apr 24
Arthritis Patients - Cigna's Evernorth To Offer Humira Biosimilar At No Out-of-Pocket Cost
ABBV
CI
CVS
26 Apr 24
BMO Capital Maintains Outperform on AstraZeneca, Raises Price Target to $82
AZN
26 Apr 24
Top 4 Health Care Stocks That May Plunge This Month
AZN
BSX
ELV
26 Apr 24
Wall Street Futures Ride High On Microsoft, Alphabet Cheer, But Will Inflation Data Burst The Bubble? Why This Analyst Thinks Bull Run Isn't Over Yet
ABBV
ALV
AN
26 Apr 24
Investor Sentiment Improves Slightly, But Dow Tumbles Over 350 Points
BMY
CVX
META
26 Apr 24
AstraZeneca, Through A Subsidiary, Will Acquire All Of Fusion's Outstanding Shares For A Price Of $21.00 Per Share In Cash At Closing Plus A Non-Transferable CVR Representing The Contingent Right To Receive $3.00/Share In Cash Payable Upon The Achievement Of A Specified Regulatory Milestone, Pursuant And Subject To The Terms And Conditions Of A Contingent Value Rights Agreement
AZN
FUSN
25 Apr 24
Is "Bad News" Still "Good News" for the Market?
AAL
AZN
CAT
25 Apr 24
AbbVie's Dermatitis Drug Shown 'Superior' To Sanofi/Regeneron's Dupixent In Head-To-Head Study
ABBV
REGN
SNY
25 Apr 24
Why Caterpillar Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
ACON
AIRE
ATNI
25 Apr 24
Press releases
AbelZeta Announces Abstract for C-CAR031 Accepted for Presentation at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
AZN
25 Apr 24
New Data Show RINVOQ® (upadacitinib) Demonstrated Superiority Versus DUPIXENT® (dupilumab) Across Primary and All Secondary Endpoints in an Open-Label Head-to-Head Atopic Dermatitis Study
ABBV
25 Apr 24
Merck Announces First-Quarter 2024 Financial Results
MRK
25 Apr 24
Q1 2024 results
AZN
25 Apr 24
Supernus Pharmaceuticals to Announce First Quarter 2024 Financial Results and Host Conference Call on May 8, 2024
SUPN
24 Apr 24
Jazz Pharmaceuticals to Present Data Across Growing Oncology Pipeline and Portfolio at ASCO 2024
JAZZ
24 Apr 24
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Supernus Pharmaceuticals, Inc. - SUPN
SUPN
24 Apr 24
United Therapeutics Announces World's First Successful Xenothymokidney Transplant
UTHR
24 Apr 24
Investment Opportunities in Biotech Amidst Federal Rate Uncertainties (ATNM)
ABBV
ATNM
AZN
22 Apr 24
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Supernus Pharmaceuticals, Inc. - SUPN
SUPN
20 Apr 24
Transcripts
ABBV
Earnings call transcript
2024 Q1
26 Apr 24
MRK
Earnings call transcript
2024 Q1
25 Apr 24
IGXT
Earnings call transcript
2023 Q4
21 Mar 24
EBS
Earnings call transcript
2023 Q4
6 Mar 24
JAZZ
Earnings call transcript
2023 Q4
28 Feb 24
SUPN
Earnings call transcript
2023 Q4
27 Feb 24
UTHR
Earnings call transcript
2023 Q4
21 Feb 24
MED
Earnings call transcript
2023 Q4
20 Feb 24
AXSM
Earnings call transcript
2023 Q4
20 Feb 24
ABBV
Earnings call transcript
2023 Q4
2 Feb 24
Patents
Utility
Modified Imidazopyridines As Glucosylceramide Synthase Inhibitors
MRK
18 Jan 24
Utility
Antibodies Targeting C5AR
MOR
18 Jan 24
Utility
Modulators of the Integrated Stress Pathway
ABBV
18 Jan 24
Utility
GHB Formulation and Method for Its Manufacture
JAZZ
18 Jan 24
Utility
Polycyclic Cap-dependent Endonuclease Inhibitors for Treating or Preventing Influenza
MRK
18 Jan 24
Utility
Methods of administering solriamfetol to lactating women
AXSM
16 Jan 24
Utility
Well plate assembly with pressure release mechanism
MRK
16 Jan 24
Utility
Methods of administering solriamfetol to lactating women
AXSM
16 Jan 24
Utility
Combination of an ANTI-CD19 Antibody and a Bruton's Tyrosine Kinase Inhibitor and Uses Thereof
MOR
11 Jan 24
Utility
PROCESSES FOR THE PREPARATION OF (3S,4R)-3-ETHYL-4-(3H-IMIDAZO[1,2-a]PYRROLO[2,3-e]-PYRAZIN-8-YL)-N-(2,2,2-TRIFLUOROETHYL)PYRROLIDINE-1-CARBOXAMIDE AND SOLID STATE FORMS THEREOF
ABBV
11 Jan 24
Reddit threads
Reuters noted that Pfizer has set a list price for Beqvez at $3.5 million in the U.S.
PFE
JNJ
GSK
27 Apr 24
What's happening in the markets: April 26th
EU
EEA
GSK
26 Apr 24
Jesus, BMY truly got hammered
BMY
ABBV
JNJ
25 Apr 24
I'm a full time trader and this is a total review of everything I've collated from premarket to inform me on all the news heading into the trading day.
META
IBM
FCF
25 Apr 24
Reality income - Just cannot dip my toes.
AA
ADC
WPC
24 Apr 24
Best Dividend stock right now?
G
ET
ARCC
20 Apr 24
All in on one or spread the love?
IBM
CVX
ABBV
20 Apr 24
How many different funds do you have in your dividend portfolio?
PDI
MSD
ARCC
19 Apr 24
Are you using this dip in the market as a buying opportunity or expecting it to tank more?
IBIT
SBUX
STT
18 Apr 24
Long-term investor checking in. Should I sell some LLY and buy some PFE?
LLY
PFE
NVO
17 Apr 24